Cannabis Business Times' Best Cannabis Companies to Work For - 2027 Is Accepting Entries! Enter now.
Cannabis Business Times' Best Cannabis Companies to Work For - 2027 Is Accepting Entries! Enter now.
Top Stories | Cannabis Business Times
Subscribe
Sign In
Continue to Site
»
Site will load in
15
seconds
Continue to Site »
X
Top Stories
Massachusetts Cannabis Repeal Petition Qualifies for 2026 Ballot; Objector Files New Challenge
The state’s Elections Division certified the final batch of signatures, but the objector is claiming that several signatures should be disqualified.
Virginia Lawmakers Respond to ‘Inaccurate Reports’ on Cannabis Sales Bill
The lawmakers who drew up the state’s adult-use sales legislation that was incorporated into the state budget refuted claims about distribution and underage possession.
Wyoming Rejects Trump Administration’s Schedule III Cannabis Listing; Keeps It Schedule I
Wyoming Attorney General Keith G. Kautz
announced that he won’t loosen restrictions on cannabis after there was little public interest in doing so.
Cannabis Prohibition Interests Don’t ‘Systemically Align’ With American Public, DOJ Says
The Department of Justice argued that anti-rescheduling groups attempting to stay a Schedule III order have ‘pocketbook interests’ in prohibition.
American Bankers Association Presses Congress to Pass SAFE Banking Act
The financial trade group for the U.S. banking industry wrote a letter to congressional leaders, urging them to co-sponsor the cannabis legislation.
Idaho Cannabis Activists Submit Signatures to State Secretary
The Natural Medicine Alliance of Idaho submitted all county-verified petition signatures for its medical cannabis legalization ballot initiative.
Newer Cannabis Drying and Curing Methods to Achieve Superior Quality
Expensive research and trials have led to newer equipment designed to enable larger-scale producers to precisely replicate the perfect environmental conditions that are conducive to drying and curing. Here are some options.
‘DEA Comes Out Swinging in Cannabis Rescheduling Hearing' Leads
CBT
’s Top Stories in June
CBT
provided an in-the-courtroom analysis of the DEA’s first witness’s testimony in support of the Schedule III proposed rule.
Prohibitionists Punch Back at Cannabis Rescheduling Hearing
Anti-rescheduling participants who oppose the Schedule III proposal attempt to expose flaws in a scientific and medical evaluation and discredit DEA witnesses.
DEA Comes Out Swinging in Cannabis Rescheduling Hearing
The government argued in support of currently accepted medical use; anti-rescheduling parties attempted to poke holes in the Schedule III recommendation.
Cannabis Remains Most Widely Used Drug Worldwide, New Report Reveals
The number of people using cannabis has grown 40% in the past decade, according to the United Nations 2026 World Drug Report.
DEA Plans to Call Pain Management Doctor, FDA Official to Testify at Cannabis Reschedule Hearing
The Drug Enforcement Administration filed a prehearing statement summarizing its two proposed witnesses’ testimony.
Page 1 of 279
Next Page
